Cybin Sees Strong Trading Volume - MarketBeat
CYBN Stock | USD 10.28 0.04 0.39% |
About 57% of Cybin's investor base is looking to short. The analysis of the overall investor sentiment regarding Cybin Inc suggests that many traders are alarmed. Cybin's investing sentiment overview a quick insight into current market opportunities from investing in Cybin Inc. Many technical investors use Cybin Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Cybin |
Cybin Sees Strong Trading Volume MarketBeat
Read at news.google.com
Cybin Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cybin can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cybin Fundamental Analysis
We analyze Cybin's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cybin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cybin based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Cybin is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cybin Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cybin stock to make a market-neutral strategy. Peer analysis of Cybin could also be used in its relative valuation, which is a method of valuing Cybin by comparing valuation metrics with similar companies.
Peers
Cybin Related Equities
ZVSA | ZyVersa Therapeutics | 5.66 | ||||
IMMX | Immix Biopharma | 5.48 | ||||
MNMD | Mind Medicine | 2.24 | ||||
VCNX | Vaccinex | 1.50 | ||||
EWTX | Edgewise Therapeutics | 1.15 | ||||
ITOS | Iteos Therapeutics | 0.97 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
MOLN | Molecular Partners | 2.13 | ||||
CNSP | Cns Pharmaceuticals | 2.36 | ||||
FBIO | Fortress Biotech | 2.83 | ||||
ATAI | ATAI Life | 3.27 | ||||
OPT | Opthea | 3.32 | ||||
BPTH | Bio Path | 3.38 | ||||
GHRS | GH Research | 4.79 | ||||
ZURA | Zura Bio | 9.71 | ||||
SEEL | Seelos Therapeutics | 22.00 |
Check out Cybin Hype Analysis, Cybin Correlation and Cybin Performance. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cybin. If investors know Cybin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cybin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.10) | Return On Assets (0.33) | Return On Equity (0.49) |
The market value of Cybin Inc is measured differently than its book value, which is the value of Cybin that is recorded on the company's balance sheet. Investors also form their own opinion of Cybin's value that differs from its market value or its book value, called intrinsic value, which is Cybin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cybin's market value can be influenced by many factors that don't directly affect Cybin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cybin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cybin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cybin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.